Surginex
PrivateLast Round
Series B
Mar 28, 2024
Total Funding Raised
$9.69M
Company Overview
Surginex is a biotechnology company that develops AI-based drug discovery platforms and next-generation lipid nanoparticle (LNP) technology for targeted drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surginex Comparables
Compare Surginex with similar companies based on industry and business-model similarity.
Surginex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 28, 2024 | ||||
| Series A | Oct 18, 2021 |
Surginex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Series B |
| POSCO Capital | Series B |
| K-Net Investment Partners | Series A |
| Kiwoom Investment | Series B |
| LSK Investment | Series B |
| Kiwoom Investment | Series B |
| Partners Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 28, 2024
$6.3M round with participation from Kiwoom Investment and POSCO Technology Investment.
Surginex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Surginex's valuation, stock price, and market status.